NM_017752.3:c.465G>T

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_017752.3(TBC1D8B):​c.465G>T​(p.Glu155Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000911 in 1,097,163 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 9.1e-7 ( 0 hom. 0 hem. )

Consequence

TBC1D8B
NM_017752.3 missense

Scores

1
5
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.629

Publications

0 publications found
Variant links:
Genes affected
TBC1D8B (HGNC:24715): (TBC1 domain family member 8B) This gene encodes a protein with a TBC (Tre-2/Bub2/CDC16) domain. Some mammalian proteins with this domain have been shown to function as Rab-GAPs by binding to specific Rab proteins and affecting their GTPase activity. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2011]
MORC4 (HGNC:23485): (MORC family CW-type zinc finger 4) In human, the four current members of the microrchidia (morc) gene family share an N-terminal ATPase-like ATP-binding region and a CW four-cysteine zinc-finger motif. The protein encoded by this gene also has a nuclear matrix binding domain and a two-stranded coiled-coil motif near its C-terminus. This gene is widely expressed at low levels in normal tissues and has elevated expression in placenta and testis. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jan 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.31511384).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TBC1D8BNM_017752.3 linkc.465G>T p.Glu155Asp missense_variant Exon 4 of 21 ENST00000357242.10 NP_060222.2 Q0IIM8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TBC1D8BENST00000357242.10 linkc.465G>T p.Glu155Asp missense_variant Exon 4 of 21 1 NM_017752.3 ENSP00000349781.5 Q0IIM8-1

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD4 exome
AF:
9.11e-7
AC:
1
AN:
1097163
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
362923
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26349
American (AMR)
AF:
0.00
AC:
0
AN:
35115
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19347
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30185
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54081
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40486
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4128
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
841424
Other (OTH)
AF:
0.00
AC:
0
AN:
46048
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
22

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 03, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.465G>T (p.E155D) alteration is located in exon 4 (coding exon 4) of the TBC1D8B gene. This alteration results from a G to T substitution at nucleotide position 465, causing the glutamic acid (E) at amino acid position 155 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
16
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.48
T;.;T;T
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.92
D;D;D;D
M_CAP
Pathogenic
0.60
D
MetaRNN
Benign
0.32
T;T;T;T
MetaSVM
Uncertain
0.027
D
MutationAssessor
Benign
0.12
N;N;.;.
PhyloP100
0.63
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-1.7
N;N;N;N
REVEL
Benign
0.20
Sift
Benign
0.063
T;T;D;T
Sift4G
Benign
0.17
T;T;T;T
Polyphen
0.13
B;.;B;.
Vest4
0.27
MutPred
0.30
Loss of ubiquitination at K156 (P = 0.0631);Loss of ubiquitination at K156 (P = 0.0631);Loss of ubiquitination at K156 (P = 0.0631);Loss of ubiquitination at K156 (P = 0.0631);
MVP
0.51
MPC
0.078
ClinPred
0.23
T
GERP RS
3.4
Varity_R
0.25
gMVP
0.20
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chrX-106065311; API